Richard A. Wells
25 Morton Shulman Avenue
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Combined results from two randomized controlled feasibility studies.
Journal: American journal of hematology
Published: September 05, 2023
Pharmacogenetics of Lethal Opioid Overdose: Review of Current Evidence and Preliminary Results from a Pilot Study.
Journal: Journal of personalized medicine
Published: May 09, 2023
Retrospective study of non-natural manners of death in Ontario: Effects of the COVID-19 pandemic and related public health measures.
Journal: Lancet regional health. Americas
Published: December 20, 2021
The Use of Cremation Data for Timely Mortality Surveillance During the COVID-19 Pandemic in Ontario, Canada: Validation Study.
Journal: JMIR public health and surveillance
Published: July 27, 2021
Intracellular ROS profile in hematopoietic progenitors of MDS patients: association with blast count and iron overload.
Journal: Hematology (Amsterdam, Netherlands)
Published: May 18, 2021
One-year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.
Journal: European journal of haematology
Published: August 27, 2020
One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study.
Journal: Therapeutic advances in hematology
Published: May 29, 2020
Revised 15-item MDS-specific frailty scale maintains prognostic potential.
Journal: Leukemia
Published: April 30, 2020
Refractory vitiligo improving with eculizumab.
Journal: Dermatologic therapy
Published: November 28, 2019
Last Updated: 09/26/2026